Integer (NYSE:ITGR – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Integer to similar companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.
Earnings and Valuation
This table compares Integer and its peers gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Integer | $1.85 billion | $102.81 million | 42.47 |
| Integer Competitors | $1.87 billion | $136.27 million | 5.88 |
Integer’s peers have higher revenue and earnings than Integer. Integer is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Integer and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Integer | 0 | 11 | 1 | 0 | 2.08 |
| Integer Competitors | 4295 | 10582 | 18367 | 832 | 2.46 |
Integer presently has a consensus target price of $113.67, suggesting a potential downside of 10.20%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.94%. Given Integer’s peers stronger consensus rating and higher possible upside, analysts plainly believe Integer has less favorable growth aspects than its peers.
Insider and Institutional Ownership
99.3% of Integer shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Integer has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, Integer’s peers have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.
Profitability
This table compares Integer and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Integer | 5.68% | 11.84% | 5.98% |
| Integer Competitors | -303.57% | -175.14% | -22.20% |
Summary
Integer peers beat Integer on 8 of the 13 factors compared.
About Integer
Integer Holdings Corporation develops and manufactures medical-device components and provides outsourced manufacturing services for medical technology companies. Its products are used in devices for cardiac rhythm management, neuromodulation, cardiovascular care, and other medical applications. The company’s offerings include batteries, capacitors, leads, catheters, and precision components, as well as engineered assemblies and manufacturing support. Integer serves medical-device original equipment manufacturers around the world.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
